Page 12198. Instead of The authors declare no competing financial interest , the following Note should be included: The authors declare the following competing financial interest(s): Y.K. is a founder and equity holder of Firebrand Therapeutics, Inc, which is developing inhibitors against MTDH/SND1. Received.
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Drug Discovery